- Release Date: 06/09/24 09:37
- Summary: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
- Price Sensitive: Yes
- Download Document 540.68KB
- Forums
- ASX - By Stock
- Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $4.225K | 222.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 0.019 |
11 | 2301165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524225 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 80000 | 1 |
0.021 | 188000 | 3 |
0.022 | 600000 | 2 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online